The Role of Hypomethylating Agents Prior to Allogeneic Hematopoietic Stem Cells Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Background & Aims. The aim of the study was to evaluate the efficacy and safety of azacytidine and decitabine prior to allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia and juvenile myelomon...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Varvara Nikolaevna Ovechkina, S. N. Bondarenko, E. V. Morozova, I. S. Moiseev, A. A. Osipova, T. L. Gindina, A. I. Shakirova, T. A. Bykova, A. D. Kulagin, I. A. Samorodova, E. V. Karyakina, E. A. Ukrainchenko, L. S. Zubarovskaya, B. V. Afanas’ev
Formatua:	Artigo
Hizkuntza:	Russo
Argitaratua:	Practical Medicine Publishing House 2017-07-01
Saila:	Клиническая онкогематология
Gaiak:	acute myeloid leukemia myelodysplastic syndrome allogeneic hematopoietic stem cell transplantation hypomethylating agents azacitidine decitabine
Sarrera elektronikoa:	https://bloodjournal.ru/index.php/coh/article/view/435
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!